PFIZER INC Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Pfizer Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Pfizer Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$441M, a 26.3% increase year-over-year.
- Pfizer Inc annual Deferred Income Tax Expense (Benefit) for 2024 was -$2.1B, a 38.9% increase from 2023.
- Pfizer Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$3.44B, a 8.56% increase from 2022.
- Pfizer Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$3.76B, a 12.3% increase from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)